US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 190 actively recruiting studies with Wisconsin sites out of 190 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Asthma, Burkitt Lymphoma. Leading sponsors running trials in the state include University of Wisconsin, Madison, National Cancer Institute (NCI), Medical College of Wisconsin. By stage, Wisconsin trials break down as Phase 1 (23), Phase 2 (49), Phase 3 (59), Phase 4 (6).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
190
Recruiting Now
190
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (6)Asthma (4)Burkitt Lymphoma (3)Metastatic Cancer (3)Acute Myeloid Leukemia (3)Ovarian Cancer (3)Stroke (3)Melanoma (3)Non-Small Cell Lung Cancer (3)Prostate Cancer (3)Multiple Myeloma (3)Metastatic Breast Cancer (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 190 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 190. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Asthma, Burkitt Lymphoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06994442 Phase 3
Recruiting
Optimizing Pain Treatment in Children On Mechanical Ventilation
Condition
Mechanical Ventilation
Enrollment
644 pts
Location
United States
Sponsor
Weill Medical College of Corne
View Trial →
NCT05222620 Phase 2
Recruiting
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIO...
Condition
Metastatic Malignant Neoplasm in the Brain
Enrollment
90 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT07250802 Phase 3
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Condition
Plaque Psoriasis
Enrollment
110 pts
Location
United States, China, Germany
Sponsor
Takeda
View Trial →
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT04973605 Phase 1, Phase 2
Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Comb...
Condition
Relapsed/Refractory Multiple Myeloma
Enrollment
246 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
View Trial →
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years ...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
4,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT05742607 Phase 2
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (M...
Condition
Non Small Cell Lung Cancer
Enrollment
70 pts
Location
United States, France, Greece
Sponsor
Innate Pharma
View Trial →
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
590 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
View Trial →
NCT04761120 N/A
Recruiting
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Condition
Mitral Regurgitation
Enrollment
550 pts
Location
United States, Estonia, France
Sponsor
Abbott Medical Devices
View Trial →
NCT01810913 Phase 2, Phase 3
Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizum...
Condition
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Enrollment
613 pts
Location
United States, Canada, Hong Kong
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05848713 Phase 3
Recruiting
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquire...
Condition
Community-acquired Pneumonia
Enrollment
4,000 pts
Location
United States, Brazil, Canada
Sponsor
University of Manitoba
View Trial →
NCT02675959 Phase 2
Recruiting
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patie...
Condition
Sickle Cell Disease
Enrollment
40 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT03550391 Phase 3
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radioth...
Condition
Brain Metastases
Enrollment
206 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT02329210 N/A
Recruiting
Clinical Registry Investigating Bardet-Biedl Syndrome
Condition
Bardet-Biedl Syndrome
Enrollment
1,200 pts
Location
United States
Sponsor
Marshfield Clinic Research Fou
View Trial →
NCT07419425 Phase 4
Recruiting
My Path to Quit Tobacco
Condition
Smoking Cessation
Enrollment
1,550 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT05950464 Phase 1
Recruiting
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the...
Condition
Recurrent Endometrial Carcinoma
Enrollment
65 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06934239 Phase 4
Recruiting
A Trial Comparing Screening Mammography With and Without Assistance From Artific...
Condition
Breast Cancer Screening
Enrollment
400,000 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
View Trial →
NCT07400926 N/A
Recruiting
Observational Trial of the Updated Inserter for the Travoprost Intracameral Impl...
Condition
Open Angle Glaucoma (OAG)
Enrollment
30 pts
Location
United States
Sponsor
Glaukos Corporation
View Trial →
NCT06411249 Phase 4
Recruiting
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Pa...
Condition
Systemic Lupus Erythematosus
Enrollment
350 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT04251052 N/A
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations t...
Condition
Ovarian Carcinoma
Enrollment
1,956 pts
Location
United States, Canada, South Korea
Sponsor
NRG Oncology
View Trial →
Page 3 of 8 — 190 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology